Catecholamine mechanisms in age-related cognitive decline
- 31 December 1993
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 14 (6) , 639-641
- https://doi.org/10.1016/0197-4580(93)90054-f
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Analysis of alpha-2 adrenergic agonist effects on the delayed nonmatch-to-sample performance of aged rhesus monkeysPublished by Elsevier ,2003
- Reserpine impairs spatial working memory performance in monkeys: reversal by the α2-adrenergic agonist clonidineBrain Research, 1993
- Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response taskPsychopharmacology, 1992
- Behavioral and receptor binding analysis of the α2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-YL amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an α2-adrenoceptor subtypeNeuropharmacology, 1991
- The effect of aging on the D1 dopamine receptors in human frontal cortexBrain Research, 1990
- Lexical priming deficits as a function of age.Behavioral Neuroscience, 1990
- The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypesJournal of Neuroscience, 1988
- α 2 -Adrenergic Mechanisms in Prefrontal Cortex Associated with Cognitive Decline in Aged Nonhuman PrimatesScience, 1985
- Heterogeneity of alpha-2 adrenergic receptorsPharmacology Biochemistry and Behavior, 1985
- Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus MonkeyScience, 1979